Price
Target price
-
-
-
-
-
?3.68
WKN: A3DMEZ / Symbol: QNRX / Name: Quoin Pharmaceuticals / Stock / Biotechnology & Medical Research / Mid Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction
Quoin Pharmaceuticals Ltd. ADR Stock
With 0 Sell predictions and 1 Buy predictions the community sentiment towards the Quoin Pharmaceuticals Ltd. ADR stock is not clear.
Based on the current price of 0.49 € the target price of 3 € shows a potential of 508.52% for Quoin Pharmaceuticals Ltd. ADR which would more than double the current price.
For the coming years our community has positive and negative things to say abot the Quoin Pharmaceuticals Ltd. ADR stock. Criterium "Worthwhile Investment for the next years" gathered the most positive votes but regarding "Unique positioning" there were negative voices in the community.
Pros and Cons of Quoin Pharmaceuticals Ltd. ADR in the next few years
Pros
?
M***** P*******
?
G***** c******* t* c**********
?
C******** o* t** e**********
Cons
?
S********** s********
?
B****
?
W********* I********* f** t** n*** y****
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Quoin Pharmaceuticals Ltd. ADR vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Quoin Pharmaceuticals Ltd. ADR | - | - | - | - | - | - | - |
| Medpace Holdings Inc | 9.480% | 4.939% | 0.476% | 121.105% | 35.338% | 139.182% | - |
| Galapagos N.V. | 1.470% | -0.722% | -9.652% | -21.751% | -25.702% | -59.127% | - |
| Taro Pharmaceutical Industries Ltd | 0.510% | 0.000% | 1.546% | 72.807% | 4.787% | -36.960% | -57.698% |
Comments
Quoin Pharmaceuticals, Ltd. (NASDAQ: QNRX) had its price target lowered by analysts at Maxim Group from $15.00 to $4.00. They now have a "buy" rating on the stock.
Show more
Ratings data for QNRX provided by MarketBeat
